These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 17244360)

  • 81. MAEL as a diagnostic marker for the early detection of esophageal squamous cell carcinoma.
    Abbaszadegan MR; Taghehchian N; Aarabi A; Akbari F; Saburi E; Moghbeli M
    Diagn Pathol; 2021 Apr; 16(1):36. PubMed ID: 33902648
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Efficacy and Safety of Ramucirumab in Asian and Non-Asian Patients with Advanced Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Individual Data Analysis of Two Randomized Studies.
    Yen CJ; Kudo M; Lim HY; Hsu CH; Vogel A; Brandi G; Cheng R; Nitu IS; Abada P; Hsu Y; Zhu AX; Kang YK
    Liver Cancer; 2020 Aug; 9(4):440-454. PubMed ID: 32999870
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Biomarkers for Hepatocellular Carcinoma.
    Lou J; Zhang L; Lv S; Zhang C; Jiang S
    Biomark Cancer; 2017; 9():1-9. PubMed ID: 28469485
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Hepatocellular carcinoma: Review of disease and tumor biomarkers.
    Kim JU; Shariff MI; Crossey MM; Gomez-Romero M; Holmes E; Cox IJ; Fye HK; Njie R; Taylor-Robinson SD
    World J Hepatol; 2016 Apr; 8(10):471-84. PubMed ID: 27057305
    [TBL] [Abstract][Full Text] [Related]  

  • 85.
    Pan Z; Tang B; Hou Z; Zhang J; Liu H; Yang Y; Huang G; Yang Y; Zhou W
    Mol Clin Oncol; 2014 Nov; 2(6):1155-1159. PubMed ID: 25279215
    [No Abstract]   [Full Text] [Related]  

  • 86. Comparing staging systems for predicting prognosis and survival in patients with hepatocellular carcinoma in Egypt.
    Gomaa AI; Hashim MS; Waked I
    PLoS One; 2014; 9(3):e90929. PubMed ID: 24603710
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Combined analysis of serum γ-glutamyl transferase isoenzyme II, α-L-fucosidase and α-fetoprotein detected using a commercial kit in the diagnosis of hepatocellular carcinoma.
    Zhu J; Jiang F; Ni HB; Xiao MB; Chen BY; Ni WK; Lu CH; Ni RZ
    Exp Ther Med; 2013 Jan; 5(1):89-94. PubMed ID: 23251247
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Comparative diagnostic efficacy of serum squamous cell carcinoma antigen in hepatocellular carcinoma.
    Soyemi OM; Otegbayo JA; Ola SO; Akere A; Soyemi T
    BMC Res Notes; 2012 Aug; 5():403. PubMed ID: 22856336
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Circulating tumor cells measurements in hepatocellular carcinoma.
    Chiappini F
    Int J Hepatol; 2012; 2012():684802. PubMed ID: 22690340
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Tumor progression-related transmembrane protein aspartate-β-hydroxylase is a target for immunotherapy of hepatocellular carcinoma.
    Shimoda M; Tomimaru Y; Charpentier KP; Safran H; Carlson RI; Wands J
    J Hepatol; 2012 May; 56(5):1129-1135. PubMed ID: 22245894
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Cancer immunotherapy takes a multi-faceted approach to kick the immune system into gear.
    Dimberu PM; Leonhardt RM
    Yale J Biol Med; 2011 Dec; 84(4):371-80. PubMed ID: 22180675
    [TBL] [Abstract][Full Text] [Related]  

  • 92. A review on laboratory liver function tests.
    Gowda S; Desai PB; Hull VV; Math AA; Vernekar SN; Kulkarni SS
    Pan Afr Med J; 2009 Nov; 3():17. PubMed ID: 21532726
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Expression and prognostic significance of cancer-testis antigens (CTA) in intrahepatic cholagiocarcinoma.
    Zhou JX; Li Y; Chen SX; Deng AM
    J Exp Clin Cancer Res; 2011 Jan; 30(1):2. PubMed ID: 21211023
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Surveillance and diagnosis of hepatocellular carcinoma in patients with cirrhosis.
    Andreana L; Isgrò G; Pleguezuelo M; Germani G; Burroughs AK
    World J Hepatol; 2009 Oct; 1(1):48-61. PubMed ID: 21160965
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Serum markers of hepatocellular carcinoma.
    Malaguarnera G; Giordano M; Paladina I; Berretta M; Cappellani A; Malaguarnera M
    Dig Dis Sci; 2010 Oct; 55(10):2744-55. PubMed ID: 20339916
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Identification of a novel human cancer/testis gene MAEL that is regulated by DNA methylation.
    Xiao L; Wang Y; Zhou Y; Sun Y; Sun W; Wang L; Zhou C; Zhou J; Zhang J
    Mol Biol Rep; 2010 Jun; 37(5):2355-60. PubMed ID: 19693694
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Spermatogenesis associated retrogenes are expressed in the human ovary and ovarian cancers.
    Rohozinski J; Anderson ML; Broaddus RE; Edwards CL; Bishop CE
    PLoS One; 2009; 4(3):e5064. PubMed ID: 19333399
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Diagnosis of hepatocellular carcinoma.
    Gomaa AI; Khan SA; Leen EL; Waked I; Taylor-Robinson SD
    World J Gastroenterol; 2009 Mar; 15(11):1301-14. PubMed ID: 19294759
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The pituitary tumor transforming gene 1 (PTTG-1): an immunological target for multiple myeloma.
    Chiriva-Internati M; Ferrari R; Prabhakar M; Yu Y; Baggoni L; Moreno J; Gagliano N; Portinaro N; Jenkins MR; Frezza EE; Hardwicke F; D'Cunha N; Kast W; Cobos E
    J Transl Med; 2008 Apr; 6():15. PubMed ID: 18384692
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Specific CD8(+ )T cell responses to HLA-A2 restricted MAGE-A3 p271-279 peptide in hepatocellular carcinoma patients without vaccination.
    Zhang HG; Chen HS; Peng JR; Shang XY; Zhang J; Xing Q; Pang XW; Qin LL; Fei R; Mei MH; Leng XS; Chen WF
    Cancer Immunol Immunother; 2007 Dec; 56(12):1945-54. PubMed ID: 17522859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.